Sacituzumab govitecan - Wikipedia
https://en.wikipedia.org/wiki/Sacituzumab_govitecan
WEBSacituzumab govitecan is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate, meaning that the drug targets the Trop-2 receptor that helps the cancer grow, divide and spread, and is linked to topoisomerase inhibitor, which is a chemical compound that is toxic to cancer cells.
DA: 43 PA: 61 MOZ Rank: 1